Johnson & Johnson

NYSE: JNJ
$154.00
+$2.13 (+1.4%)
Closing Price on November 15, 2024

JNJ Articles

Now that we are out of the woods in the crash scenario, assuming this week is no ill omen, investors may want to know which of the big companies would start to deploy their billions and billions of...
Wasn’t it just last week that we were up eight days in a row on the DJIA?  And now we have a sell-the-news reaction to the recent growth numbers.  Maybe it is because we ran too far too fast and...
Reuters:   UBS (UBS) shares may fall when the Swiss government sells out. Reuters:   The US deficit estimate was trimmed to $1.59 trillion. Reuters:   A homeowner sued Wells Fargo (WFC) over a...
Berkshire Hathaway Inc. (NYSE: BRK-A)(BRK-B) has released its Q2-2009  public equity holdings as of June 30, 2009.  There are some portfolio changes that have been seen here from the end of Q1 and...
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The...
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Reuters:   The US may give CIT (CIT) short term loans. Reuters:   Intel (INTC) issued a positive forecast and indicated that the PC market may be improving. Reuters:   The US CPI was up more...
DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates.  The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues...
Reuters:   Smart investors are starting to cherry- pick stocks. Reuters:   California may agree on a budget to stop using IOUs. Reuters:   Some stock funds are still making up for lost ground....
Reuters:   Cybercrime is spreading fast on Facebook. Reuters:   GM will seek to sell most of its assets to a new company. Reuters:    Madoff got 150 years in prison. Reuters:   AIG (AIG)...
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 –...
Palomar Medical Technologies Inc. (NASDAQ: PMTI) is seeing shares surge to new heights not seen in 18-months.  The company is the first to receive FDA approval for over-the-counter clearance for a...
These are the few top pre-market analyst downgrades or cautious research calls from Wall Street firms this Friday morning with about two hours until the market opens: Burger King (BKC) Cut to Hold at...
The first quarter of 2009 Warren Buffett and Berkshire Hathaway Inc. (NYSE: BRK-A)(BRK-B) holdings are now out for the cut off date here of March 31, 2009.  There are some changes from the end of...
Investors flock to defensive stocks in times of trouble and and when they worry, assuming they look to stay in the market when they are worried.  But if the trend here continues, this may be one of...